Rivastigmin Sandoz 4,6 mg/24 Stunden - transdermales Pflaster
Active ingredient: RIVASTIGMIN
View notice details →News topic
Notice identifier: BASG-ID 069dc1a4f217c8f283f1507fd36b959db73df72e; Zulassungsnummer 135339
All current shortage notices related to Notice identifier: BASG-ID 069dc1a4f217c8f283f1507fd36b959db73df72e; Zulassungsnummer 135339, structured by product, country, active ingredient and reporting period.
1 noticesPlan supply. Connect sourcing and warehousing.
For pharmacies, wholesalers and manufacturers: choose the service matching your operational need.
Improve sourcing and supply availability
Researching this shortage professionally? We assess sourcing routes, suppliers and cross-border supply against your requirements. A notice does not confirm stock availability.
Send a sourcing enquiry →Pharma warehouse and pharmaceutical warehousing in Cheb
Medicine storage, batch and expiry control, picking and distribution for Germany and Europe. We agree the storage profile, temperature and capacity with you.
Request warehouse capacity →